Medicare Enrolled
Dr. Brent Limbaugh, M.D., PH.D.
Hematology & Oncology · Augusta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Limbaugh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Limbaugh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Limbaugh
Dr. Brent Limbaugh is a hematology & oncology specialist in Augusta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Limbaugh performed 151,978 Medicare services across 6,205 unique beneficiaries.
Between the years covered by Open Payments, Dr. Limbaugh received a total of $93,784 from 110 pharmaceutical and/or device companies across 1464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Limbaugh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in GA
$93,784 industry payments
Medicare Practice Summary
Medicare Utilization ↗151,978
Medicare services
Top 3% in GA for hematology & oncology
6,205
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,999 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
39,780 | $0 | $2 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
36,750 | $1 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
12,900 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
12,385 | $2 | $6 |
| Pembrolizumab injection (Keytruda) | 11,400 | $43 | $105 |
| Paclitaxel chemotherapy injection | 8,636 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 8,400 | $18 | $47 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,943 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,416 | $8 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,314 | $7 | $67 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,100 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,776 | $10 | $67 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,230 | $1 | $2 |
| Injection, granisetron hydrochloride, 100 mcg | 1,220 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
920 | $88 | $263 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
554 | $20 | $100 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
552 | $13 | $50 |
| Iron level test | 454 | $6 | $40 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
450 | $12 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
448 | $90 | $693 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
409 | $10 | $75 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
354 | $2 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
332 | $56 | $155 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
280 | $6 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
233 | $129 | $299 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
189 | $61 | $140 |
| PSA test (prostate cancer screening) | 166 | $18 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
154 | $44 | $120 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
152 | $15 | $56 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
152 | $1 | $5 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 143 | $20 | $75 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
140 | $19 | $150 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
133 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
104 | $45 | $150 |
| Red blood cell folate level test A blood test that measures the amount of folic acid stored inside red blood cells to assess long-term folate status. |
100 | $17 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
97 | $89 | $209 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
91 | $9 | $207 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
83 | $51 | $350 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
72 | $19 | $75 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
70 | $16 | $60 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
64 | $3 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 64 | $130 | $450 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
56 | $3 | $10 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
56 | $14 | $50 |
| New patient office visit, complex (60-74 min) | 55 | $160 | $500 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
54 | $1 | $2 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
52 | $20 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
50 | $1 | $1 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
49 | $8 | $28 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
49 | $11 | $75 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
48 | $22 | $220 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 36 | $20 | $60 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
35 | $14 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $133 | $380 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
28 | $23 | $236 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
27 | $6 | $22 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
27 | $14 | $30 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $38 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $121 | $400 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
19 | $220 | $695 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
16 | $78 | $516 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
15 | $4 | $10 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
14 | $35 | $214 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.3% high complexity
41.2% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$93,784
Total received (2018-2024)
Avg $13,398/year across 7 years
Top 6% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
110
Companies
1,464
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$61,445 (65.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,400 (23.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,939 (10.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,184
2023
$5,053
2022
$5,470
2021
$5,231
2020
$16,775
2019
$27,680
2018
$29,393
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$367
Merck Sharp & Dohme LLC
$351
AstraZeneca Pharmaceuticals LP
$283
PFIZER INC.
$261
Gilead Sciences, Inc.
$223
E.R. Squibb & Sons, L.L.C.
$215
Stemline Therapeutics Inc.
$204
ABBVIE INC.
$167
Genentech USA, Inc.
$157
BeiGene USA, Inc.
$120
Regeneron Healthcare Solutions, Inc.
$104
Alexion Pharmaceuticals, Inc.
$102
Daiichi Sankyo Inc.
$93
Bayer Healthcare Pharmaceuticals Inc.
$90
Astellas Pharma US Inc
$84
Kite Pharma, Inc.
$80
Celgene Corporation
$77
Janssen Biotech, Inc.
$75
ARRAY BIOPHARMA INC
$70
EMD Serono, Inc.
$68
Lilly USA, LLC
$68
Takeda Pharmaceuticals U.S.A., Inc.
$67
Dendreon Pharmaceuticals LLC
$66
Aveo Pharmaceuticals, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$52
TAIHO ONCOLOGY, INC.
$51
Ipsen Biopharmaceuticals, Inc
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Sumitomo Pharma America, Inc.
$44
Incyte Corporation
$40
Deciphera Pharmaceuticals Inc.
$36
Eisai Inc.
$35
Exelixis Inc.
$32
Siemens Medical Solutions USA, Inc.
$29
Fennec Pharmaceuticals, Inc.
$28
GENZYME CORPORATION
$25
PUMA BIOTECHNOLOGY, INC.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Karyopharm Therapeutics Inc.
$20
Blueprint Medicines Corporation
$20
GlaxoSmithKline, LLC.
$19
SpringWorks Therapeutics, Inc.
$18
Octapharma USA, Inc.
$17
Acrotech Biopharma Inc.
$17
Agios Pharmaceuticals, Inc.
$17
SOBI, INC
$16
Organogenesis Inc.
$16
PharmaEssentia USA Corporation
$16
Genmab U.S., Inc.
$15
ADC Therapeutics America, Inc.
$15
Rigel Pharmaceuticals, Inc.
$11
Aspira Women's Health Inc
$7
Top 3 companies account for 23.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$13,818
Celgene Corporation
$7,610
Regeneron Healthcare Solutions, Inc.
$6,603
E.R. Squibb & Sons, L.L.C.
$5,755
Pharmacyclics LLC, An AbbVie Company
$5,640
Bayer HealthCare Pharmaceuticals Inc.
$5,509
AbbVie, Inc.
$5,044
Janssen Biotech, Inc.
$4,149
Incyte Corporation
$3,678
AMAG Pharmaceuticals, Inc.
$3,151
Novocure Inc.
$3,144
Kite Pharma, Inc.
$2,550
PFIZER INC.
$2,442
CTI BioPharma Corp.
$2,039
AbbVie Inc.
$1,786
Seattle Genetics, Inc.
$1,786
Novartis Pharmaceuticals Corporation
$1,720
Blueprint Medicines Corporation
$1,516
Genentech USA, Inc.
$1,262
Coherus Biosciences Inc.
$1,139
GENZYME CORPORATION
$1,127
Merck Sharp & Dohme Corporation
$882
Merck Sharp & Dohme LLC
$830
Astellas Pharma US Inc
$619
Gilead Sciences, Inc.
$524
Exelixis Inc.
$476
Seagen Inc.
$466
BeiGene, Ltd.
$450
Daiichi Sankyo Inc.
$441
GlaxoSmithKline, LLC.
$439
Octapharma USA, Inc.
$363
Eisai Inc.
$325
Boehringer Ingelheim Pharmaceuticals, Inc.
$292
Taiho Oncology, Inc.
$283
Takeda Pharmaceuticals U.S.A., Inc.
$281
Alexion Pharmaceuticals, Inc.
$254
Stemline Therapeutics Inc.
$252
Puma Biotechnology, Inc.
$234
BeiGene USA, Inc.
$230
Lilly USA, LLC
$211
TAIHO ONCOLOGY, INC.
$210
ABBVIE INC.
$198
EMD Serono, Inc.
$193
Karyopharm Therapeutics Inc.
$171
ARRAY BIOPHARMA INC
$162
Athenex Pharmaceutical Division, LLC
$150
JAZZ PHARMACEUTICALS INC.
$147
Ipsen Biopharmaceuticals, Inc
$146
TerSera Therapeutics LLC
$140
Dendreon Pharmaceuticals LLC
$138
PUMA BIOTECHNOLOGY, INC.
$129
Deciphera Pharmaceuticals Inc.
$127
Bayer Healthcare Pharmaceuticals Inc.
$114
Adaptive Biotechnologies Corporation
$102
Rigel Pharmaceuticals, Inc.
$96
Pharmacyclics LLC, an AbbVie Company
$96
Boston Scientific Corporation
$93
Myovant Sciences Inc.
$91
EISAI INC.
$90
G1 Therapeutics, Inc.
$89
AVEO Pharmaceuticals, Inc.
$89
Kyowa Kirin, Inc.
$83
Aveo Pharmaceuticals, Inc.
$81
Clovis Oncology, Inc.
$77
Heron Therapeutics, Inc.
$74
Acrotech Biopharma Inc.
$72
Sun Pharmaceutical Industries Inc.
$68
Sumitomo Pharma America, Inc.
$65
Amgen Inc.
$60
Foundation Medicine, Inc.
$58
Verastem, Inc.
$57
TESARO, Inc.
$51
Acrotech Biopharma LLC
$49
Aurobindo Pharma USA, Inc.
$48
SANOFI-AVENTIS U.S. LLC
$42
ADC Therapeutics America, Inc.
$41
Agios Pharmaceuticals, Inc.
$40
Genmab U.S., Inc.
$36
Jazz Pharmaceuticals Inc.
$36
Mylan Institutional Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$35
Lexicon Pharmaceuticals, Inc.
$34
Shire North American Group Inc
$34
EUSA Pharma (US) LLC
$33
Spectrum Pharmaceuticals Inc.
$33
Siemens Medical Solutions USA, Inc.
$29
Fennec Pharmaceuticals, Inc.
$28
Epizyme, Inc.,
$28
Pharmacosmos Therapeutics Inc.
$28
Helsinn Therapeutics (U.S.), Inc.
$27
Janssen Pharmaceuticals, Inc
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Secura Bio, Inc.
$20
Sirtex Medical Inc
$20
SpringWorks Therapeutics, Inc.
$18
Partner Therapeutics, Inc.
$18
SOBI, INC
$16
Organogenesis Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
PharmaEssentia USA Corporation
$16
Array BioPharma Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$15
MorphoSys, US Inc.
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
TG THERAPEUTICS, INC.
$13
Sobi, Inc
$13
Dova Pharmaceuticals
$12
Acceleron Pharma, Inc.
$12
INSYS Therapeutics Inc
$11
Aspira Women's Health Inc
$7
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · ARIA Radiation Therapy Management Software · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRIUMVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · Gazyva · General - Structural Heart · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LOKELMA · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Leukine · LifeVest · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OVA1 · Ogivri · Oncology · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PURAPLY FRANCHISE · PYRUKYND · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TREMFYA · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for hematology & oncology in GA.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
13.6
County median income
$53,197
Nearest hospital
PIEDMONT AUGUSTA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Limbaugh is a mixed practice specialist, with above-average Medicare volume (top 3% in GA), with consulting-driven industry engagement in the top 6% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Limbaugh experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Limbaugh performed 39,780 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Limbaugh receive payments from pharmaceutical companies?
Yes. Dr. Limbaugh received a total of $93,784 from 110 companies across 1,464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Limbaugh's costs compare to other hematology & oncology specialists in Augusta?
Dr. Limbaugh's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Limbaugh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Augusta
Browse hematology & oncology specialists in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology